Sivelestat (Neutrophil Elastase Inhibitor) as Anti-inflammatory and Anti-viral Agent: An In Silico Study

Divya Rajagopal, Radhakrishnan Narayanaswamy, Vasantha-Srinivasan Prabhakaran

Open source

DOI
10.7759/cureus.56846
Published
2024-03-24
Container
Cureus
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.56846,
  title = {Sivelestat (Neutrophil Elastase Inhibitor) as Anti-inflammatory and Anti-viral Agent: An In Silico Study},
  author = {Divya Rajagopal and Radhakrishnan Narayanaswamy and Vasantha-Srinivasan Prabhakaran},
  year = {2024},
  journal = {Cureus},
  doi = {10.7759/cureus.56846},
  url = {https://doi.org/10.7759/cureus.56846}
}

RIS

TY  - JOUR
TI  - Sivelestat (Neutrophil Elastase Inhibitor) as Anti-inflammatory and Anti-viral Agent: An In Silico Study
AU  - Divya Rajagopal
AU  - Radhakrishnan Narayanaswamy
AU  - Vasantha-Srinivasan Prabhakaran
PY  - 2024
JO  - Cureus
DO  - 10.7759/cureus.56846
UR  - https://doi.org/10.7759/cureus.56846
ER  - 

APA

Rajagopal, D., Narayanaswamy, R., & Prabhakaran, V. (2024). Sivelestat (Neutrophil Elastase Inhibitor) as Anti-inflammatory and Anti-viral Agent: An In Silico Study. Cureus. https://doi.org/10.7759/cureus.56846

Source records